Evidence map›Paper›PMID 39316256›Full record

ArticleJournal of molecular histology2024

Effects of Platycodon grandiflorus on doxorubicin resistance and epithelial-mesenchymal transition of breast cancer cells via the p38 mitogen-activated protein kinase pathway.

Wen Yun, Junying Zhang, Minghua Ji

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular histology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wen YunDepartment of General Surgery, Jiangsu Cancer Hospital, Nanjing, Jiangsu Province, 210009, China.
Junying ZhangJiangsu Cancer Hospital, Nanjing, Jiangsu Province, 210009, China.
Minghua JiDepartment of Radiation Therapy, Jiangsu Cancer Hospital, Nanjing, Jiangsu Province, 210009, China. yinxiandi2346@163.com.ORCID https://orcid.org/0009-0002-7590-5931

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the increase of chemotherapy frequency for breast cancer, the drug resistance rate of patients is rising, accompanied by cell invasion and metastasis, thus causing mortality. We aimed to explore the mechanism by which Platycodon grandiflorus affects breast cancer cells in terms of the doxorubicin (Dox) resistance and epithelial-mesenchymal transition (EMT) via the p38 mitogen-activated protein kinase (p38 MAPK) signaling pathway. MCF-7/R cell lines with resistance to Dox were established. After 24 h of culture with DMEM (blank group), they were divided into Platycodon grandiflorus, Platycodon grandiflorus + Ophiopogon japonicus, Platycodon grandiflorus + Curcumae Rhizoma, Platycodon grandiflorus + Curcumae Rhizoma + U46619 groups. Flow cytometry, colony formation assay, as well as Transwell assay were performed to examine the cells for apoptosis, proliferation, and invasion, respectively. Western blotting was performed to measure the phosphorylated (p)-p38 MAPK-to-p38 MAPK ratio together with N-cadherin, vimentin, β-catenin, and E-cadherin protein expressions. Compared with the blank group, the half maximal inhibitory concentration (IC

Indexed as

ApoptosisBreast NeoplasmsDoxorubicinDrug Resistance, NeoplasmEpithelial-Mesenchymal Transitionp38 Mitogen-Activated Protein KinasesPlatycodonCell Line, TumorCell MovementCell ProliferationFemaleHumansMAP Kinase Signaling SystemMCF-7 CellsPlant ExtractsDoxorubicinp38 Mitogen-Activated Protein KinasesPlant ExtractsBreast cancerDoxorubicinEpithelial-mesenchymal transitionp38 mitogen-activated protein kinasePlatycodon grandiflorus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.